Innate Pharma News

Innate Pharma | 20-F: Registration statement / Annual report / Transition report

Apr 4 08:10 ET

Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)

Mar 21 09:26 ET

Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)

Mar 21 06:06 ET

Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)

Mar 14 07:03 ET

Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)

Feb 6 17:09 ET

Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)

Nov 14, 2023 06:00 ET

Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)

Oct 19, 2023 06:00 ET

Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)

Sep 14, 2023 06:27 ET

Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)

Sep 14, 2023 06:00 ET

Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)

May 10, 2023 06:01 ET

Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)

Apr 26, 2023 16:02 ET

Innate Pharma | 20-F/A: Registration statement / Annual report / Transition report (Amendment)

Apr 20, 2023 08:47 ET

Innate Pharma: FY2022 Annual Report

20-F | Innate Pharma SA (0001598599) (Filer)

Apr 6, 2023 06:41 ET

Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)

Mar 23, 2023 06:00 ET

Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)

Mar 16, 2023 06:01 ET

Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)

Nov 14, 2022 06:07 ET

Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)

Oct 20, 2022 06:00 ET

Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)

Sep 15, 2022 06:12 ET

Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)

May 10, 2022 06:04 ET

Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)

May 3, 2022 17:08 ET